| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-68 |
Sentence |
denotes |
Design of liposomes for circumventing the reticuloendothelial cells. |
| T1 |
0-68 |
Sentence |
denotes |
Design of liposomes for circumventing the reticuloendothelial cells. |
| T1 |
0-68 |
Sentence |
denotes |
Design of liposomes for circumventing the reticuloendothelial cells. |
| TextSentencer_T2 |
69-155 |
Sentence |
denotes |
Two different aspects of liposomal drug delivery to non-RES cells have been described. |
| T2 |
69-155 |
Sentence |
denotes |
Two different aspects of liposomal drug delivery to non-RES cells have been described. |
| T2 |
69-155 |
Sentence |
denotes |
Two different aspects of liposomal drug delivery to non-RES cells have been described. |
| TextSentencer_T3 |
156-367 |
Sentence |
denotes |
In one of the systems, by incorporating neutral glycolipids, with terminal beta-galactoside residue into liposomes, it is possible to target liposomes to the liver parenchymal cells, partially bypassing the RES. |
| T3 |
156-367 |
Sentence |
denotes |
In one of the systems, by incorporating neutral glycolipids, with terminal beta-galactoside residue into liposomes, it is possible to target liposomes to the liver parenchymal cells, partially bypassing the RES. |
| T3 |
156-367 |
Sentence |
denotes |
In one of the systems, by incorporating neutral glycolipids, with terminal beta-galactoside residue into liposomes, it is possible to target liposomes to the liver parenchymal cells, partially bypassing the RES. |
| TextSentencer_T4 |
368-431 |
Sentence |
denotes |
Asialoganglioside seems to be the most suited for this purpose. |
| T4 |
368-431 |
Sentence |
denotes |
Asialoganglioside seems to be the most suited for this purpose. |
| T4 |
368-431 |
Sentence |
denotes |
Asialoganglioside seems to be the most suited for this purpose. |
| TextSentencer_T5 |
432-540 |
Sentence |
denotes |
In another approach, various factors that prolong the lifespan of circulating liposomes have been discussed. |
| T5 |
432-540 |
Sentence |
denotes |
In another approach, various factors that prolong the lifespan of circulating liposomes have been discussed. |
| T5 |
432-540 |
Sentence |
denotes |
In another approach, various factors that prolong the lifespan of circulating liposomes have been discussed. |
| TextSentencer_T6 |
541-634 |
Sentence |
denotes |
It is possible to design such liposomes by imparting hydrophilicity to the liposomal surface. |
| T6 |
541-634 |
Sentence |
denotes |
It is possible to design such liposomes by imparting hydrophilicity to the liposomal surface. |
| T6 |
541-634 |
Sentence |
denotes |
It is possible to design such liposomes by imparting hydrophilicity to the liposomal surface. |
| TextSentencer_T7 |
635-766 |
Sentence |
denotes |
The effectiveness of a number of possible candidates, such as dextran, GM1 ganglioside and PEG, has been discussed in this context. |
| T7 |
635-766 |
Sentence |
denotes |
The effectiveness of a number of possible candidates, such as dextran, GM1 ganglioside and PEG, has been discussed in this context. |
| T7 |
635-766 |
Sentence |
denotes |
The effectiveness of a number of possible candidates, such as dextran, GM1 ganglioside and PEG, has been discussed in this context. |